financetom
Market
financetom
/
Market
/
Stock expert Sudarshan Sukhani recommends buy on Ajanta Pharma & Indusind Bank
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stock expert Sudarshan Sukhani recommends buy on Ajanta Pharma & Indusind Bank
May 28, 2019 3:09 AM

Sudarshan Sukhani of s2analytics.com, Kiran Jadhav of KiranJadhav.com and Gaurav Bissa of LKP Securities discusses with Prashant Nair and Ekta Batra their readings and outlook on market technical and F&O side of the market as well as specific stocks and sectors. They also answered viewer stock queries.

They also spoke at length on Ajanta Pharma, Indusind Bank, Yes Bank, Petronet LNG, Pidilite Industries.

Sudarshan Sukhani stock picks are, “Ajanta Pharma is a buying opportunity. It has come in my list earlier also, it is one pharma stock that is doing well. Other are having so much confusion in their charts so buy Ajanta Pharma. Indusind Bank itself independently showing some momentum on the upside.”

Kiran Jadhav stock recommendations are, “I have two buy calls Petronet LNG is one buy call stop loss is Rs 247.80 which is very near the current market price and target would be Rs 254-256 which should be achieved by today evening or maybe by tomorrow early morning. Pidilite Industries is doing good rounds of demand stop loss is Rs 1,251 and target is Rs 1,280-1,290 for the day.”

Follow stock recommendations by Sudarshan Sukhani here: https://www.cnbctv18.com/author/sudarshan-sukhani-159/

Disclaimer

: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Tech
Sector Update: Tech
Jun 16, 2025
08:49 AM EDT, 06/16/2025 (MT Newswires) -- Technology stocks were rising premarket Monday with the Technology Select Sector SPDR Fund (XLK) up 0.8% and the SPDR S&P Semiconductor ETF (XSD) nearly 6% higher recently. Roku ( ROKU ) and Amazon ( AMZN ) Ads have teamed up to create an integrated advertising platform for connected television in the US, the...
Stocks Rise Pre-Bell as Traders Monitor Israel-Iran Conflict; Await Fed Policy Meeting
Stocks Rise Pre-Bell as Traders Monitor Israel-Iran Conflict; Await Fed Policy Meeting
Jun 16, 2025
07:18 AM EDT, 06/16/2025 (MT Newswires) -- The benchmark US stock measures were pointing higher before the opening bell Monday as investors watch the ongoing conflict between Israel and Iran, while preparing for a key policy decision by the Federal Reserve later in the holiday-shortened week. The S&P 500 and the Dow Jones Industrial Average rose 0.4% each in premarket...
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid Ongoing Middle East Conflict
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid Ongoing Middle East Conflict
Jun 16, 2025
08:12 AM EDT, 06/16/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.5% and the actively traded Invesco QQQ Trust (QQQ) was 0.6% higher in Monday's premarket activity amid the ongoing Middle East conflict. US stock futures were higher, with S&P 500 Index futures up 0.5%, Dow Jones Industrial Average...
Sector Update: Health Care
Sector Update: Health Care
Jun 16, 2025
08:58 AM EDT, 06/16/2025 (MT Newswires) -- Health care stocks were steady premarket Monday with the Health Care Select Sector SPDR Fund (XLV) edging up 0.01% and the iShares Biotechnology ETF (IBB) inactive recently. Sarepta Therapeutics ( SRPT ) shares fell by 40% after the company said it is temporarily suspending shipments of Elevidys for non-ambulatory patients with Duchenne muscular...
Copyright 2023-2026 - www.financetom.com All Rights Reserved